Affiliations 

  • 1 School of Biological Sciences & Engineering, Yachay Tech University, San Miguel de Urcuquí, Ecuador
  • 2 Centro Universitário ENIAC, São Paulo, Brazil
  • 3 Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston Salem, NC, United States
  • 4 Dogs & Cats Hospital Veterinario, Ibarra, Imbabura, Ecuador
  • 5 One Health Brazilian Resistance Project (OneBR), São Paulo, Brazil
  • 6 Federal Institute of Espírito Santo, Vila Velha, Brazil
  • 7 Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • 8 Department of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil
Front Cell Infect Microbiol, 2023;13:1259764.
PMID: 39840255 DOI: 10.3389/fcimb.2023.1259764

Abstract

From a One Health perspective, dogs and cats have begun to be recognized as important reservoirs for clinically significant multidrug-resistant bacterial pathogens. In this study, we investigated the occurrence and genomic features of ESβL producing Enterobacterales isolated from dogs, in the province of Imbabura, Ecuador. We identified four isolates expressing ESβLs from healthy and diseased animals. In this regard, two Escherichia coli strains producing CTX-M-55-like or CTX-M-65 ESβLs belonged to the international ST10 and ST162, whereas two Klebsiella pneumoniae producing CTX-M-14 or CTX-M-27 belonged to ST35 and ST661. Phylogenomic analysis clustered (95-105 SNP differences) CTX-M-55/ST10 E. coli from companion animal with food and human E. coli strains of ST10 isolated in 2016, in Australia and Cambodia, respectively; whereas CTX-M-27-positive K. pneumoniae ST661 was clustered (201-216 SNP differences) with human strains identified in Italy, in 2013 and 2017, respectively. In summary, we report the presence and genomic data of global human-associated clones of CTX-M-producing E. coli and K. pneumoniae in dogs, in Ecuador. The implementation of a national epidemiological surveillance program is necessary to establish future strategies to control the dissemination of antibiotic-resistant priority pathogens using a One Health approach.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications